Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Carlos M. Ramírez-Acosta"'
Publikováno v:
Nanomaterials, Vol 10, Iss 9, p 1857 (2020)
Nanomedicine is entering a high maturity stage and is ready to reach full translation into the clinical practice. This is because of the ample spectrum of applications enabled by a large arsenal of nanostructured materials. In particular, bimetallic
Externí odkaz:
https://doaj.org/article/6dc8de78217d411c9832ed8be9109034
Autor:
Carlos M. Ramírez-Acosta, Javier Cifuentes, Maria Claudia Castellanos, Rodolfo José Moreno, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 561 (2020)
Over the past decade, gene therapies have attracted much attention for the development of treatments for various conditions, including cancer, neurodegenerative diseases, protein deficiencies, and autoimmune disorders. Despite the benefits of this ap
Externí odkaz:
https://doaj.org/article/108a5e9793f74ff08032fd8f40a32284
Publikováno v:
Nanomaterials, Vol 10, Iss 1857, p 1857 (2020)
Nanomaterials
Nanomaterials
Nanomedicine is entering a high maturity stage and is ready to reach full translation into the clinical practice. This is because of the ample spectrum of applications enabled by a large arsenal of nanostructured materials. In particular, bimetallic
Autor:
Carolina Muñoz-Camargo, Luis H. Reyes, Javier Cifuentes, Rodolfo José Moreno, Carlos M Ramírez-Acosta, Juan C. Cruz, Maria Claudia Castellanos
Publikováno v:
Pharmaceutics, Vol 12, Iss 561, p 561 (2020)
Pharmaceutics
Volume 12
Issue 6
Pharmaceutics
Volume 12
Issue 6
Over the past decade, gene therapies have attracted much attention for the development of treatments for various conditions, including cancer, neurodegenerative diseases, protein deficiencies, and autoimmune disorders. Despite the benefits of this ap
Autor:
Hector Javier Luna-Wandurraga, Luis H. Reyes, Jorge Eduardo Marroquín-Fandiño, Juan C. Cruz, Juan D. Valderrama-Rincon, Joaquín Andrés Valderrama-Rincón, Carlos M Ramírez-Acosta
Publikováno v:
Journal of biotechnology. 324
Many researchers have limited access to fully equipped laboratory-scale batch bioreactors and chemostats due to their relatively high cost. This becomes particularly prohibitive when multiple replicas of the same experiment are required, but not enou